Pharmacogenomics of mycophenolic acid in kidney transplantation
Contribution of immune response-related genes
DOI:
https://doi.org/10.1590/s2175-97902022e201188Keywords:
Immunosuppressive therapy, Mycophenolic acid, Kidney transplantation, Pharmacogenomics, Immune responseAbstract
Mycophenolic acid (MPA) inhibits IMPDH, involved in the guanosine nucleotides synthesis, and prevents DNA replication in immune cells. The repression of cell and humoral immunity by MPA induces allograft tolerance preventing acute rejection in solid organ transplantation. MPA is an effective and safe drug, but genetic and non-genetic factors have been implicated in the interindividual variability of drug response. Several studies have shown the impact of variants of pharmacokinetics or pharmacodynamics-related genes on MPA response in kidney transplantation. This review explored further the influence of genes involved in the immune response on clinical outcomes of kidney recipients on short- or long-term MPA treatment. Variants in genes related to T cell activation (CD28, CTL4, ICOS, PDPC1), pro-inflammatory cytokines (IL2, IL6, IL12A, IL12B, TNF, IFNG), immunomodulatory cytokines (IL4, IL10, TGFB1), and innate immune response (CD14, TLR2, TLR4) were shown to be associated with increased risk of acute rejection, graft function or survival, chronic graft nephropathy, viral infections or MPA-induced myelotoxicity. Some of the significant pharmacogenetic associations were confirmed by meta-analyses of kidney transplantation. These findings are suggestive that variants in immune response-related genes contribute to the variability of MPA response, and have potential application as biomarkers of acute rejection in kidney transplantation.
Downloads
References
Abdolvahabi R, Sarrafnejad A, Nafar M, Jafari D, Razaghi E, Lessan-Pezashki M, et al. Association between TLR2, TLR4, and CD14 gene polymorphisms and acute rejection in kidney transplant. Exp Clin Transplant. 2018;16(1):31-37.
Alves LV, Martins SR, Simões E Silva AC, Cardoso CN, Gomes KB, Mota APL. TNF, IL-6, and IL-10 cytokines levels and their polymorphisms in renal function and time after transplantation. Immunol Res. 2020;68(5):246-254.
Azarpira N, Aghdai MH, Raisjalali GA, Darai M, Tarahi MJ. Influence of recipient and donor IL-10, TNFA and INFG genotypes on the incidence of acute renal allograft rejection. Mol Biol Rep. 2009;36(6):1621-1626.
Bendickova K, Fric J. Roles of IL-2 in bridging adaptive and innate immunity, and as a tool for cellular immunotherapy. J Leukoc Biol. 2020;108(1):427-437.
Bentata Y. Mycophenolates: The latest modern and potent immunosuppressive drugs in adult kidney transplantation: What we should know about them? Artif Organs. 2020;44(6):561-576.
Canossi A, Aureli A, Delreno F, Iesari S, Cervelli C, Clemente K, et al. Influence of cytotoxic T-lymphocyte antigen-4 polymorphisms on acute rejection onset of cadaveric renal transplants. Transplant Proc. 2013;45(7):2645-2649.
Cargnin S, Galli U, Lee KS, Shin JI, Terrazzino S. Gene polymorphisms and risk of acute renal graft rejection: A field synopsis of meta-analyses and genome-wide association studies. Transplant Rev (Orlando). 2020;34(3):100548.
Chen Z, Bouamar R, Van Schaik RH, De Fijter JW, Hartmann A, Zeier M, et al. Genetic polymorphisms in IL-2, IL-10, TGF-β1, and IL-2RB and acute rejection in renal transplant patients. Clin Transplant. 2014;28(6):649-655.
Cilião HL, Camargo-Godoy RBO, de Souza MF, Dos Reis MB, Iastrenski L, Alvares Delfino VD, et al. Association of UGT2B7, UGT1A9, ABCG2, and IL23R polymorphisms with rejection risk in kidney transplant patients. J Toxicol Environ Health, Part A. 2017;80(13-15):661-671.
da Silva MB, da Cunha FF, Terra FF, Camara NO. Old game, new players: Linking classical theories to new trends in transplant immunology. World J Transplant. 2017;7(1):1-25.
Dhaouadi T, Sfar I, Bardi R, Jendoubi-Ayed S, Abdallah TB, Ayed K, et al. Cytokine gene polymorphisms in kidney transplantation. Transplant Proc . 2013;45(6):2152-2157.
Dmitrienko S, Hoar DI, Balshaw R, Keown PA. Immune response gene polymorphisms in renal transplant recipients. Transplantation. 2005;80(12):1773-1782.
Duan Z, Zhang Y, Pan F, Zhang T, Zeng Z, Wang S, et al. Association between CTLA4 gene polymorphisms and acute rejection of kidney transplantation: a meta-analysis. J Nephrol. 2012;25(6):996-1002.
Eiamsitrakoon T, Tharabenjasin P, Pabalan N, Tasanarong A. Influence of Interferon gamma +874 T>A (rs2430561) polymorphism on renal allograft rejection: A meta-analysis. Transplant Proc . 2020;S0041-1345(20):32704-4.
Ferreira PCL, Thiesen FV, Pereira AG, Zimmer AR, Fröehlich PE. A short overview on mycophenolic acid pharmacology and pharmacokinetics. Clin Transplant . 2020;34(8):e13997.
Gaafar A, Iqniebi A, Sheereen A, Eldali A, Turpeinen H, Adra C, et al. Study of the cytokine polymorphisms in correlation to rejection and graft survival in renal allograft donors and recipients from a homogenous Saudi population. Transpl Immunol. 2014;30(1):34-39.
Gao JW, Guo YF, Fan Y, Qiu JX, Bao ED, Liu Y, et al. Polymorphisms in cytotoxic T lymphocyte associated antigen-4 influence the rate of acute rejection after renal transplantation in 167 Chinese recipients. Transpl Immunol . 2012;26(4):207-211.
Gao JW, Zhou ZH, Guo SC, Guo YF, Guo F. A deeper understanding of the association between CTLA4 +49A/G and acute rejection in renal transplantation: an updated meta-analysis. Ren Fail. 2015;37(1):165-174.
Ge YZ, Wu R, Jia RP, Liu H, Yu P, Zhao Y, et al. Association between Interferon gamma +874 T>A polymorphism and acute renal allograft rejection: evidence from published studies. Mol Biol Rep . 2013;40(10):6043-6051.
Ge YZ, Wu R, Lu TZ, Jia RP, Li MH, Gao XF, et al. Combined effects of TGFB1 +869 T/C and +915 G/C polymorphisms on acute rejection risk in solid organ transplant recipients: a systematic review and meta-analysis. PLoS One. 2014a;9(4):e93938.
Ge YZ, Yu P, Jia RP, Wu R, Ding AX, Li LP, et al. Association between transforming growth factor beta-1 +869T/C polymorphism and acute rejection of solid organ allograft: A meta-analysis and systematic review. Transpl Immunol . 2014b;30(2-3):76-83.
Gendzekhadze K, Rivas-Vetencourt P, Montano RF. Risk of adverse post-transplant events after kidney allograft transplantation as predicted by CTLA-4 +49 and TNF- alpha -308 single nucleotide polymorphisms: a preliminary study. Transpl Immunol . 2006;16(3-4):194-199. https://doi.org/10.1016/j.trim.2006.09.001.
» https://doi.org/https://doi.org/10.1016/j.trim.2006.09.001
Genvigir FDV, Cerda A, Hirata TDC, Hirata MH, Hirata RDC. Mycophenolic acid pharmacogenomics in kidney transplantation. J Transl Genet Genom. 2020;4(4):320-355. http://dx.doi.org/10.20517/jtgg.2020.37.
» https://doi.org/http://dx.doi.org/10.20517/jtgg.2020.37
Genvigir FDV, Nishikawa AM, Felipe CR, Tedesco-Silva H Jr, Oliveira N, Campos-Salazar AB, et al. Influence of ABCC2, CYP2C8, and CYP2J2 polymorphisms on tacrolimus and mycophenolate sodium-based treatment in brazilian kidney transplant recipients. Pharmacotherapy. 2017;37(5):535-545.
Grenda R, Prokurat S, Ciechanowicz A, Piatosa B, Kaliciński P. Evaluation of the genetic background of standard-immunosuppressant-related toxicity in a cohort of 200 paediatric renal allograft recipients--a retrospective study. Ann Transplant. 2009;14(3):18-24.
Grinyó J, Vanrenterghem Y, Nashan B, Vincenti F, Ekberg H, Lindpaintner K, et al. Association of four DNA polymorphisms with acute rejection after kidney transplantation. Transpl Int. 2008;21(9):879-891.
Guo M, Wang ZJ, Yang HW, Meng L, Tan RY, Gu M, et al. Influence of genetic polymorphisms on mycophenolic acid pharmacokinetics and patient outcomes in renal transplantation. Curr Drug Metab. 2018;19(14):1199-1205.
Guo Y, Guo F, Wei C, Qiu J, Liu Y, Fang Y, et al. CTLA4 gene polymorphisms influence the incidence of infection after renal transplantation in Chinese recipients. PLoS One . 2013;8(8):e70824.
Haimila K, Turpeinen H, Alakulppi NS, Kyllönen LE, Salmela KT, Partanen J. Association of genetic variation in inducible costimulator gene with outcome of kidney transplantation. Transplant. 2009;87(3):393-396.
Han FF, Fan H, Wang ZH, Li GR, Lv YL, Gong LL, et al. Association between co-stimulatory molecule gene polymorphism and acute rejection of allograft. Transpl Immunol . 2014;31(2):81-86.
Hoffmann TW, Halimi JM, Büchler M, Velge-Roussel F, Al- Najjar A, Marliere JF, et al. Impact of a polymorphism in the IL-12p40 gene on the outcome of kidney transplantation. Transplant Proc . 2009;41(2):654-656.
Hoffmann TW, Halimi JM, Büchler M, Velge-Roussel F, Goudeau A, Al-Najjar A, et al. Association between a polymorphism in the IL-12p40 gene and cytomegalovirus reactivation after kidney transplantation. Transplant ation . 2008;85(10):1406-1411.
Hoffmann TW, Halimi JM, Büchler M, Velge-Roussel F, Goudeau A, Al-Najjar A, et al. Association between a polymorphism in the human programmed death-1 (PD-1) gene and cytomegalovirus infection after kidney transplantation. J Med Genet. 2010;47(1):54-58.
Hu Q, Tian H, Wu Q, Li J, Cheng X, Liao P. Association between Interleukin-2 -330 T/G polymorphism and acute renal graft rejection: A meta-analysis. Transplant Proc . 2015;47(6):1746-1753.
Hu Q, Tian H, Wu Q, Li J, Cheng X, Liao P. Interleukin-10-1082 G/a polymorphism and acute renal graft rejection: a meta- analysis. Ren Fail . 2016;38(1):57-64.
Hu R, Barratt DT, Coller JK, Sallustio BC, Somogyi AA. No major effect of innate immune genetics on acute kidney rejection in the first 2 weeks post-transplantation. Front Pharmacol. 2020;10:1686.
Hu X, Bai Y, Li S, Zeng K, Xu L, Liu Z, et al. Donor or recipient TNF-A -308G/A polymorphism and acute rejection of renal allograft: A meta-analysis. Transpl Immunol . 2011;25(1):61-71.
Jacobson PA, Schladt D, Oetting WS, Leduc R, Guan W, Matas AJ, et al. Genetic determinants of mycophenolate- related anemia and leukopenia after transplantation. Transplant ation . 2011;91(3):309-316.
Karimi MH, Daneshmandi S, Pourfathollah AA, Geramizadeh B, Yaghobi R, Rais-Jalali GA, et al. A study of the impact of cytokine gene polymorphism in acute rejection of renal transplant recipients. Mol Biol Rep . 2012;39(1):509-515.
Kiang TKL, Ensom MHH. Population pharmacokinetics of mycophenolic acid: An update. Clin Pharmacokinet. 2018;57(5):547-558.
Krichen H, Gorgi Y, Dhaouadi T, Mecheri Y, Sfar I, Bardi R, et al. Toll-like receptor 4 and CD14 gene polymorphisms in Tunisian kidney transplantation. Transplant Proc . 2013;45(10):3472-3477.
Krüger B, Banas MC, Walberer A, Böger CA, Farkas S, Hoffmann U, et al. A comprehensive genotype-phenotype interaction of different Toll-like receptor variations in a renal transplant cohort. Clin Sci (Lond). 2010;119(12):535-544.
Kusztal M, Kościelska-Kasprzak K, Drulis-Fajdasz D, Magott-Procelewska M, Patrzałek D, Janczak D. et al. The influence of CTLA-4 gene polymorphism on long-term kidney allograft function in Caucasian recipients. Transpl Immunol . 2010;23(3):121-124.
Li HY, Zhou T, Lin S, Lin W. Relationship between TGF-β1 + 869 T/C and + 915 G/C gene polymorphism and risk of acute rejection in renal transplantation recipients. BMC Med Genet. 2019;20(1):113.
Li LQ, Chen DN, Li CJ, Li QP, Chen Y, Fang P, et al. Impact of UGT2B7 and ABCC2 genetic polymorphisms on mycophenolic acid metabolism in Chinese renal transplant recipients. Pharmacogenomics. 2018;19(17):1323-1334.
Liu K, Gu S, Liu X, Sun Q, Wang Y, Meng J, et al. Impact of inducible co-stimulator gene polymorphisms on acute rejection in renal transplant recipients: An updated systematic review and meta-analysis. Meta Gene. 2017a;12:118-124.
Liu K, Liu X, Gu S, Sun Q, Wang Y, Meng J, et al. Association between TGFB1 genetic polymorphisms and chronic allograft dysfunction: a systematic review and meta- analysis. Oncotarget. 2017b;8(37):62463-62469.
Lv R, Hu X, Bai Y, Long H, Xu L, Liu Z, et al. Association between IL-6 -174G/C polymorphism and acute rejection of renal allograft: evidence from a meta-analysis. Transpl Immunol . 2012;26(1):11-18.
Misra MK, Kapoor R, Pandey SK, Sharma RK, Agrawal S. Association of CTLA-4 gene polymorphism with end- stage renal disease and renal allograft outcome. J Interferon Cytokine Res. 2014;34(3):148-161.
Misra MK, Pandey SK, Kapoor R, Sharma RK, Agrawal S. Cytotoxic T-lymphocyte antigen 4 gene polymorphism influences the incidence of symptomatic human cytomegalovirus infection after renal transplantation. Pharmacogenet Genomics. 2015;25(1):19-29.
Niknam A, Karimi MH, Geramizadeh B, Roozbeh J, Yaghobi R, Salehipour M. Polymorphisms of the costimulatory genes CTLA-4, CD28, PD-1, and ICOS and outcome of kidney transplants in Iranian patients. Exp Clin Transplant . 2017;15(3):295-305.
Pawlik A, Dabrowska-Zamojcin E, Dziedziejko V, Safranow K, Domanski L. Association between IVS3 +17T/C CD28 gene polymorphism and the acute kidney allograft rejection. Transpl Immunol . 2014;30(2-3):84-87.
Perovic V, Markovic M, Kravljaca M, Milosevic E, Djoric M, Pravica V, et al. Cytokine gene polymorphism profiles in kidney transplant patients - association of +1188A/C RS3212227 SNP in the IL12B gene prevents delayed graft function. Arch Med Res. 2018;49(2):101-108.
Ruhi Ç, Sallakçi N, Yeğin O, Süleymanlar G, Ersoy FF. The influence of CTLA-4 single nucleotide polymorphisms on acute kidney allograft rejection in Turkish patients. Clin Transplant. 2015;29(7):612-618.
Sakharkar P, Deb S, Mashayekhi N. Association between polymorphisms in cytokine gene and viral infections in renal and liver transplant recipients: A systematic review. J Pharm Pharm Sci. 2020;23(1):109-131.
Sánchez-Fructuoso AI, Pérez-Flores I, Valero R, Moreno MA, Fernandez-Arquero M, Urcelay E, et al. The polymorphism -308G/A of Tumor Necrosis Factor-α gene modulates the effect of immunosuppressive treatment in first kidney transplant subjects who suffer an acute rejection. J Immunol Res . 2016;2016:2197595.
Santiago JL, Pérez-Flores I, Sánchez-Pérez L, Moreno de la Higuera MA, Calvo-Romero N, Querol-García J, et al. The Interferon-Gamma +874 A/T polymorphism is not associated with cmv infection after kidney transplantation. Front Immunol. 2020;10:2994.
Satoh S, Saito M, Inoue K, Miura M, Komatsuda A, Habuchi T. Association of cytokine polymorphisms with subclinical progressive chronic allograft nephropathy in Japanese renal transplant recipients: preliminary study. Int J Urol. 2007;14(11):990-994.
Singh R, Kesarwani P, Ahirwar DK, Kapoor R, Mittal RD. Interleukin 8 -251T>A and Interferon gamma +874A>T polymorphism: potential predictors of allograft outcome in renal transplant recipients from north India. Transpl Immunol . 2009;21(1):13-17.
Smith AJ, Humphries SE. Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev. 2009;20(1):43-59.
Staatz CE, Tett SE. Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update. Arch Toxicol. 2014;88(7):1351-1389.
Stojanova J, Pouché L, Picard N. Genetic polymorphisms in the immune response: A focus on kidney transplantation. Clin Biochem. 2016;49(4-5):363-376.
Thakkinstian A, Dmitrienko S, Gerbase-Delima M, McDaniel DO, Inigo P, Chow KM, et al. Association between cytokine gene polymorphisms and outcomes in renal transplantation: a meta-analysis of individual patient data. Nephrol Dial Transplant . 2008;23(9):3017-3023.
Viklický O, Hubácek JA, Kvasnicka J, Matl I, Voska L, Skibová J, et al. Association of methylenetetrahydrofolate reductase T677 allele with early development of chronic allograft nephropathy. Clin Biochem . 2004;37(10):919-924.
Vu D, Sakharkar P, Shah T, Naraghi R, Yasir Q, Hutchinson I, et al. Association of interferon gamma gene polymorphisms with BK virus infection among Hispanic renal allograft recipients. Transplant ation . 2014a;97(6):660-667.
Vu D, Shah T, Ansari J, Sakharkar P, Yasir Q, Naraghi R, et al. Interferon-gamma gene polymorphism +874 A/T is associated with an increased risk of cytomegalovirus infection among Hispanic renal transplant recipients. Transplant Infect Dis. 2014b;16(5):724-732.
Weimer R, Mytilineos J, Feustel A, Preiss A, Daniel V, Grimm H, et al. Mycophenolate mofetil-based immunosuppression and cytokine genotypes: effects on monokine secretion and antigen presentation in long-term renal transplant recipients. Transplantation . 2003;75(12):2090-2099.
Woillard JB, Picard N, Thierry A, Touchard G, Marquet P; DOMINOS study group. Associations between polymorphisms in target, metabolism, or transport proteins of mycophenolate sodium and therapeutic or adverse effects in kidney transplant patients. Pharmacogenet Genomics . 2014;24(5):256-262.
Wu W, Liu Y, Li S, Hu L, Sun X, Cai L, et al. Association between IL-4 polymorphism and acute rejection of solid organ allograft: a meta-analysis. Gene. 2013;513(1):14-21.
Xiong J, Wang Y, Zhang Y, Nie L, Wang D, Huang Y, et al. Lack of association between interleukin-10 gene polymorphisms and graft rejection risk in kidney transplantation recipients: A meta-analysis. PLoS One . 2015;10(6):e0127540.
Yang CH, Chen XX, Chen L, Zheng DH, Liu QS, Xie WF, et al. Relationship between cytotoxic T-lymphocyte antigen 4 -318C/T (rs5742909) gene polymorphism and the risk of acute rejection in renal transplantation. Pediatr Transplant . 2017a;21(7): e12920.
Yang CH, Chen XX, Chen L, Zheng DH, Liu QS, Xie WF. Association of cytotoxic T-lymphocyte antigen 4 +49A/G gene polymorphism with acute rejection risk in renal transplantation. Pediatr Transplant . 2017b;21(4):e12916.
Zaza G, Granata S, Tomei P, Dalla Gassa A, Lupo A. Personalization of the immunosuppressive treatment in renal transplant recipients: the great challenge in “omics” medicine. Int J Mol Sci. 2015;16(2):4281-4305.
Zheng M, Yang H, Li W, Zhou J, Wei J, Wang Z, et al. A single- nucleotide polymorphism (rs1131243) of the Transforming Growth Factor Beta signaling pathway contributes to risk of acute rejection in chinese renal transplant recipients. Med Sci Monit. 2019;25:9138-9158.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on-line journal has open and free access.
